Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON

(JNJ)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations
The feature you requested does not exist. However, we suggest the following feature:

FBI probes J&J, Siemens, GE, Philips in Brazil graft case bribery

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/20/2019 | 05:43am EDT

US Federal Bureau of Investigation (FBI) had been investigating some of multinational corporate giants such as Johnson & Johnson, General Electric Co., Siemens AG and Philips for allegedly paying millions to Brazilian government officials as part of a conspiration linked to selling medical equipment on the largest Latin American market, two officials of Brazilian financial watchdog had unveiled on Friday, the 17th of May 2019.

In point of fact, Brazilian investigator had been assuming that the beforementioned multinational conglomerates had been funneling illegal payoffs to government officials in order to secure contracts of public health programs across South America over the past two decades.

Apart from that, Brazilian officials had also added that there might been a cartel of more than 20 companies involved in bribing government officials to inflate price of medical equipment such as MRI (Magnetic Resonance Imaging) machines and prosthetics.

The four multinational companies with a market capitalization of $600 billion on Fridays (April 17th) market closure, are the largest foreign businesses to be probed by Brazilian anti-trust authorities over the recent years.

Concomitantly, over the past five years, Brazilian prosecutors had unveiled wide-ranging state institutions and private-sector companies had been seeking to engage in businesses with them.

(c) 2019 Global Data Point. All Rights Reserved. Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers

Stocks mentioned in the article
ChangeLast1st jan.
GENERAL ELECTRIC COMPANY -1.28% 10 Delayed Quote.32.10%
JOHNSON & JOHNSON 0.29% 138.61 Delayed Quote.7.41%
SIEMENS -0.78% 106.56 Delayed Quote.10.31%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on JOHNSON & JOHNSON
05:43aFBI probes J&J, Siemens, GE, Philips in Brazil graft case bribery
AQ
05/19Modi’s jobs deficit - J&J’s largest India plant idle three years ..
RE
05/18JOHNSON & JOHNSON : J&J unveils top pipeline prospects, with main focus on cance..
AQ
05/17EXCLUSIVE : FBI targets Johnson & Johnson, Siemens, GE, Philips in Brazil graft ..
RE
05/17JOHNSON & JOHNSON : to Participate in Bernstein's 35th Annual Strategic Decision..
PR
05/17“MY LIFE'S MISSION IS FINDING : Meet the Lead Scientist on a Promising Fe..
PU
05/15JOHNSON & JOHNSON : Outlines Strategy to Deliver Above-Market Growth at 2019 Pha..
PR
05/15JOHNSON & JOHNSON : German Merck shows new data backing BTK drug evobrutinib in ..
AQ
05/14JOHNSON & JOHNSON : Janssen Demonstrates Strong Commitment to Inflammatory Bowel..
PU
05/13JOHNSON & JOHNSON : Janssen Pharmaceutical - New Study Finds Chronic Kidney Dise..
AQ
More news
Financials ($)
Sales 2019 81 174 M
EBIT 2019 25 487 M
Net income 2019 19 737 M
Debt 2019 9 323 M
Yield 2019 2,71%
P/E ratio 2019 19,50
P/E ratio 2020 17,72
EV / Sales 2019 4,65x
EV / Sales 2020 4,28x
Capitalization 368 B
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 148 $
Spread / Average Target 6,7%
EPS Revisions
Managers
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Charles O. Prince Independent Director
William David Perez Independent Director
Anne M. Mulcahy Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON7.41%368 017
PFIZER-4.99%230 570
ROCHE HOLDING LTD.9.35%227 259
NOVARTIS13.20%210 489
MERCK AND COMPANY3.02%202 676
ABBVIE-13.81%117 468